Literature DB >> 31805399

Ectonucleotide pyrophosphatase 2 (ENPP2) plays a crucial role in myogenic differentiation through the regulation by WNT/β-Catenin signaling.

Jay Prakash Sah1, Nguyen Thi Thu Hao1, Xianghua Han2, Trinh Thi Tuyet Tran1, Sarah McCarthy2, Younjeong Oh3, Jeong Kyo Yoon4.   

Abstract

Ectonucleotide pyrophosphate phosphodiesterase type II (ENPP2), also known as Autotaxin (ATX), is an enzyme present in blood circulation that converts lysophosphatidyl choline (LPC) to lysophosphatidic acid (LPA). While LPA has been demonstrated to play diverse roles in skeletal myogenesis, mainly through in vitro studies, the role of ENPP2 in skeletal myogenesis has not been determined. We previously found that Enpp2 is induced by a positive WNT/β-Catenin signaling regulator, R-spondin2 (RSPO2), in C2C12 myoblast cells. As RSPO2 promotes myogenic differentiation via the WNT/β-Catenin signaling pathway, we hypothesized that ENPP2 may act as a key mediator for the crosstalk between WNT and LPA signaling during myogenic differentiation. Herein, we found that ENPP2 function is essential for myogenic differentiation in C2C12 cells. Pharmacological ENPP2 inhibitors or RNAi-mediated Enpp2 gene knockdown severely impaired the myogenic differentiation, including the cell fusion process, whereas administration of the recombinant ENPP2 protein enhanced myogenic differentiation. Consistent with the in vitro results, mice lacking the Enpp2 gene showed a disrupted muscle regeneration after acute muscle injury. The size of newly regenerated myofibers in Enpp2 mutant muscle was significantly reduced compared with wild-type regenerated muscle. Modified expression patterns of myogenic markers in Enpp2 mutant muscle further emphasized the impaired muscle regeneration process. Finally, we convincingly demonstrate that the Enpp2 gene is a direct transcriptional target for WNT/β-Catenin signaling. Functional TCF/LEF1 binding sites within the upstream region of Enpp2 gene were identified by chromatin immunoprecipitation using anti-β-Catenin antibodies and reporter assay. Our study reveals that ENPP2 is regulated by WNT/β-Catenin signaling and plays a key positive role in myogenic differentiation.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autotaxin; ENPP2; LPA; Muscle regeneration; Myogenic differentiation; WNT/β-Catenin

Year:  2019        PMID: 31805399     DOI: 10.1016/j.biocel.2019.105661

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  5 in total

1.  Global transcriptomic analysis reveals Lnc-ADAMTS9 exerting an essential role in myogenesis through modulating the ERK signaling pathway.

Authors:  Liqi Wang; Ting He; Xin Zhang; Yubo Wang; Kai Qiu; Ning Jiao; Linjuan He; Jingdong Yin
Journal:  J Anim Sci Biotechnol       Date:  2021-02-02

2.  The landscape of chromatin accessibility in skeletal muscle during embryonic development in pigs.

Authors:  Jingwei Yue; Xinhua Hou; Xin Liu; Ligang Wang; Hongmei Gao; Fuping Zhao; Lijun Shi; Liangyu Shi; Hua Yan; Tianyu Deng; Jianfei Gong; Lixian Wang; Longchao Zhang
Journal:  J Anim Sci Biotechnol       Date:  2021-05-03

Review 3.  The linkage between inflammation and fibrosis in muscular dystrophies: The axis autotaxin-lysophosphatidic acid as a new therapeutic target?

Authors:  Felipe S Gallardo; Adriana Córdova-Casanova; Enrique Brandan
Journal:  J Cell Commun Signal       Date:  2021-03-10       Impact factor: 5.782

4.  A Six-Gene Risk Model Based on the Immune Score Reveals Prognosis in Intermediate-Risk Acute Myeloid Leukemia.

Authors:  Cong Lu; Dong Hu; Jin'e Zheng; Shiyi Cao; Jiang Zhu; Xiangjun Chen; Shiang Huang; Junxia Yao
Journal:  Biomed Res Int       Date:  2022-04-29       Impact factor: 3.246

5.  R-Spondin2, a Positive Canonical WNT Signaling Regulator, Controls the Expansion and Differentiation of Distal Lung Epithelial Stem/Progenitor Cells in Mice.

Authors:  Ahmed A Raslan; Youn Jeong Oh; Yong Ri Jin; Jeong Kyo Yoon
Journal:  Int J Mol Sci       Date:  2022-03-13       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.